Journal of the Korean neurological association (대한신경과학회지)

Korean Neurological Association (대한신경과학회)
권호 표지

The Reliability and Validity of The Migraine-Specific Quality of Life Questionnaire for Korean Migraine Suffers

한국인 편두통 환자에서 MSQoL (Migraine-Specific Quality of Life) 설문조사의 신뢰도 및 타당도

Moon, Heui-Soo;Chung, Chin-Sang;Lee, Hye-Seung;Park, Hye-Sun;Kim, Seon-Woo;Woo, Haing-Won
문희수;정진상;이혜승;박혜선;김선우;우행원

  • Published : 20030400
⟨ Previous Next ⟩

Abstract

Background: Recurrent, often unpredictable, migraine attacks significantly interfere with daily functioning and productivity of patients with migraine. Quality of life measurement represents an important tool for evaluating migraine therapy and judging the impact of headache either on individuals or on society. The objective of this study was to test the reliability and validity of the translated version of MSQoL (Migraine-Specific Quality of Life) in Korean migraine patients. Methods: Participants, migraineurs from the Samsung Medical Center Migraine Clinic, were screened using the International Headache Society migraine criteria prior to enrollment through direct interview. This survey included the MSQoL, MIDAS (Migraine Disability assessment) and STAI (State-Trait Anxiety Inventory). Results: Sixty-five migraineurs were recruited. For the MSQoL, Cronbach's alpha was 0.93. Frequency and number of accompanying symptoms were predictive of the MSQoL. The negative correlation between the MSQoL scores and the MIDAS score was seen (r=-0.585, p<0.01). Similarly a negative correlation between the MSQoL scores and duration of headache was also observed (r=-0.38, p<0.01). Although a significant negative correlation between the MSQoL and STAI scores was present (r=-0.47, p<0.01), correlation between the MIDAS and the STAI scores was not significant. Conclusions: The MSQoL is a reliable and valuable migraine-specific quantitative tool to assess the degree of quality of life in Korean migraineurs. It has a potential to provide valuable information on migraineur's disability and anxiety level. The MSQoL has acceptable psychometric properties and can be used to estimate long-term outcome of migraine therapy in Korean population.

Keywords

References

  1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8:1-96. https://doi.org/10.1046/j.1468-2982.1988.0801001.x
  2. Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992;12:221-228. https://doi.org/10.1046/j.1468-2982.1992.1204221.x
  3. Silberstein SD, Lipton RB. Headache epidemiology. Emphasis on migraine. Neurol Clin 1996;14:421-434. https://doi.org/10.1016/S0733-8619(05)70265-6
  4. Lee TG, Chung KC, Choi JW. Prevalence of migraine in Korean adult: A nationwide Survey. Korean Journal of Headache 2000;1:57-66.
  5. Henryk-Gutt R. Rees WL. Psychological aspects of migraine. J Psychosom Res 1973;17:141-153. https://doi.org/10.1016/0022-3999(73)90015-9
  6. Breslau N. Davis GC. Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia. 1992;12:85-90.
  7. Dahlof CGH, Dimenas E. Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia 1995;15:31-36. https://doi.org/10.1046/j.1468-2982.1995.1501031.x
  8. Solomon GD. Evolution of the measurement of quality of life in migraine. Neurology. 1997;48:S10-15.
  9. Smith R. Impact of migraine on the family. Headache. 1998;38:423-426. https://doi.org/10.1046/j.1526-4610.1998.3806423.x
  10. Honkasalo ML, Kaprio J, Heikkila K, Sillanpaa M, Koskenvuo M. A population based survey of headache and migraine in 22,809 adult. Headache 1993;33:403-412. https://doi.org/10.1111/j.1526-4610.1993.hed3308403.x
  11. Stewart WF. Lipton RB. Celentano DD. Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69
  12. Dahlof CGH. Health-related quality of life under six months treatment of migraine-an open clinic-based longitudinal study. Cephalagia 1995;15:414-422. https://doi.org/10.1046/j.1468-2982.1995.1505414.x
  13. Lipton RB. Stewart WF. Sawyer J. Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment(MIDAS)questionnaire. Headache. 2001;41:854-861.
  14. Wagner TH, Patrick DL, Galer BS, Berzon RA. A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache 1996;36:484-492. https://doi.org/10.1046/j.1526-4610.1996.3608484.x
  15. Hye-Seung Lee, Chin-Sang Chung, Hee-Jung Song, Hye-Sun Park. The reliability and validity of the MIDAS(Migraine Disability Assessment) Questionnaire for Korean migraine suffers. J Korean Neurol Assoc 2000;18:287-291.
  16. Mushet GR. Miller D. Clements B. Pait G. Gutterman DL. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine. Headache. 1996;36:137-143.
  17. Lisa K, Glen D. Quality of life in migraine. Clin Neurosci 1998;5:38-42.
  18. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, Calif. Consulting Psychologists Press. 1970.
  19. 김정택, 신동균. STAI의 한국표준화에 대한 연구. 최신의학 1978;21:73-81.
  20. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychmetrika 1951;16:297-334. https://doi.org/10.1007/BF02310555
  21. 조수진, 정진상, 김수정. 한국에서 처방없이 살 수 있는 두통약의 종류와 특징. 대한신경과학회지 1998;16(부록1):99-104.
  22. Jhingran P, Cady RK, Rubino J, Miller D, Grice RB, Gutterman DL. Improvements in health-related quality of life with sumatriptan treatment for migraine. J Fam Prac 1996;42:36-42.
  23. Jane T, Raymond J, Barbara Gangek, John E. Measuring the functional status and well-being of patients with migraine headache. Headache 1994;34:337-343. https://doi.org/10.1111/j.1526-4610.1994.hed3406337.x
  24. Sheftell FD. Role and impact of over-the-counter medications in the management of headache. Neurol Clin 1997;15:187-198. https://doi.org/10.1016/S0733-8619(05)70303-0
  25. Guyatt GH, Feeny DH, Patrick DL Measuring health-related quality of life. Ann Intern Med 1993;118:622-629.
  26. Jaeschke R, Guyatt GH. How to develop and validate a new quality of life instrument. In: Spilker B. Guide to clin - ical trials. 1st ed. New York: Raven Press, 1991;975-992.
  27. Jacobson GP, Ramadan NM, Aggarwal SK, Newman CW. The Henry Ford Hospital Headache Disability Inventory(HDI). Neurology 1994;44:837-842. https://doi.org/10.1212/WNL.44.5.837
  28. Stewart WF, Lipton RB, Kolodner J, Sawyer J. Reliability of the migraine disability assessment score in a population based sample of headache suffers. Cephalalgia 1999;19:107-114. https://doi.org/10.1046/j.1468-2982.1999.019002107.x
  29. Nunnally JC. Psychometric theory. In: Silvano A. American handbook of psychiatry. 2nd ed. New York: Basic Books, 1978;229-246.
  30. Merikangas KR, Angst J, Isler H. Migraine and depression: association and familial transmission. J Psychiatr Res 1988;22:119-129. https://doi.org/10.1016/0022-3956(88)90076-3
  31. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders and suicide attempts: an epidemiologic study of young adults. Psychiatr Res 1991;37:11-23. https://doi.org/10.1016/0165-1781(91)90102-U
  32. Stewart WF Linet MS, Celentano DD. Migraine headaches and panic attacks. Psychosom Med 1989;51:559-569. https://doi.org/10.1097/00006842-198909000-00007
  33. Baskin SM. Personality and migraine. Headache 1995;35:380-381. https://doi.org/10.1111/j.1526-4610.1995.hed3507380.x
  34. Brandt J, Celentano D, Stewart W, Linet M, Folstein MF. Personality and emotional disorder in a community sample of migraine headache suffers. Am J Psychiatry 1990;147:303-308. https://doi.org/10.1176/ajp.147.3.303